Anti-ADAMTS-6 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the thrombospondin domain of human ADAMTS-6, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Dog
UniProt
Q9UKP5
Size
100ug
Cat. #
RP5ADAMTS6

In stock

SKU
RP-ADAMTS6

Options

As low as: $130.00

Target Overview

ADAMTS-6 (a disintegrin and metalloproteinase with thrombospondin motifs 6, EC 3.4.24.-) is a secreted metalloprotease localized to the extracellular matrix. The protein belongs to the ADAMTS family of zinc-dependent proteases characterized by a metalloproteinase domain, disintegrin-like domain, and one or more thrombospondin type 1 repeats. ADAMTS-6 is encoded by the ADAMTS6 gene and produces a 1,117 amino acid protein (UniProt Q9UKP5). While the precise substrate repertoire of ADAMTS-6 remains incompletely characterized, members of the ADAMTS family are known to remodel extracellular matrix components and regulate cell adhesion, migration, and tissue morphogenesis. Recent work has implicated ADAMTS-6 in epithelial-mesenchymal transition in lung adenocarcinoma and identified epigenetic silencing of ADAMTS6 in non-small-cell lung cancer. The enzyme's expression and activity are relevant to investigators studying connective tissue biology, tumor microenvironments, and developmental processes. Triple Point Biologics offers five rabbit polyclonal antibodies targeting ADAMTS-6, with immunogens mapped to the thrombospondin domain region.

Background

The ADAMTS protease family comprises 19 mammalian members with diverse roles in matrix remodeling, hemostasis, and morphogenesis. ADAMTS-6 shares the canonical domain architecture but has been less extensively studied than related family members such as ADAMTS-1, -4, and -5. Expression patterns and substrate specificity suggest involvement in developmental processes and tissue homeostasis, though functional studies remain limited compared to other family members. Mutations in ADAMTS family genes have been associated with connective tissue disorders, and a 2026 review by Alcocer et al provides a systematic overview of ADAMTS and ADAMTSL mutations in these clinical contexts. Recent investigations have focused on ADAMTS-6 in cancer biology. Odarenko et al (2025) examined the role of ADAMTS6 in epithelial-mesenchymal transition of lung adenocarcinoma cells, identifying it as a modulator of cell morphology and migration. Complementary work by Szmajda-Krygier et al (2025) assessed methylation patterns in ADAMTS family genes in non-small-cell lung cancer, finding evidence of epigenetic regulation that may contribute to tumor progression. These findings position ADAMTS-6 as a candidate biomarker and potential mechanistic player in lung cancer pathophysiology. The extracellular matrix localization of ADAMTS-6 makes it accessible to antibody-based detection methods in tissue sections and conditioned media. Researchers studying matrix remodeling, tumor microenvironments, or developmental signaling pathways may benefit from tools that detect endogenous ADAMTS-6 expression and distribution. The thrombospondin domain-targeted antibodies from Triple Point Biologics have been validated in human samples by Western blot, with predicted cross-reactivity in canine samples based on sequence homology.

References

  1. Alcocer AD et al (2026) ADAMTS and ADAMTSL mutations in connective tissue disorders. Physiology (Bethesda). PubMed · doi:10.1152/physiol.00043.2025
  2. Odarenko KV et al (2025) Deciphering the Role of ADAMTS6 in the Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Cells. Int J Mol Sci. PubMed · doi:10.3390/ijms262411850
  3. Szmajda-Krygier D et al (2025) Assessment of Methylation in Selected ADAMTS Family Genes in Non-Small-Cell Lung Cancer. Int J Mol Sci. PubMed · doi:10.3390/ijms26030934

Additional Specifications

Gene Symbol ADAMTS6
UniProt ID Q9UKP5
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Dog
Pack Size 100ug
Immunogen (Thrombospondin domain #2)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 840-900.
Immunogen (First furin cleavage site of the propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 236-247.
Immunogen (Propeptide domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-244.
Immunogen (Metalloproteinase domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 250-468.
Immunogen (Metalloproteinase domain)Synthetic peptide corresponding to the Metalloproteinase domain of human ADAMTS-6 (UniProt Q9UKP5).
Alternate Names A disintegrin and metalloproteinase with thrombospondin motifs 6, ADAM-TS 6, ADAM-TS6, ADAMTS-6, EC 3.4.24.-

Frequently Asked Questions

What molecular weight should I expect for ADAMTS-6 on a Western blot?

Full-length ADAMTS-6 has a predicted molecular weight of approximately 123 kDa based on the 1,117 amino acid sequence (UniProt Q9UKP5). However, because ADAMTS-6 is a secreted glycoprotein with extensive post-translational modifications, the apparent molecular weight often runs higher, typically between 130-150 kDa on reducing SDS-PAGE. You may also observe lower molecular weight bands representing proteolytic processing fragments, which is common for ADAMTS family members. The pattern can vary depending on cell type and whether you are analyzing lysate, conditioned medium, or extracellular matrix preparations.

What dilution should I start with for Western blot with this ADAMTS-6 antibody?

Start at 1:1000 dilution in your blocking buffer for Western blot, as recommended for this antibody. This concentration typically provides good signal-to-noise with overnight incubation at 4°C. If you are working with conditioned medium or samples with low ADAMTS-6 expression, you may need to adjust to 1:500. Always run a dilution series (1:500, 1:1000, 1:2000) with your specific sample type during initial optimization, as ADAMTS-6 expression levels vary considerably across cell lines and tissues. Extracellular matrix preparations often require more concentrated antibody than whole cell lysates.

Is this ADAMTS-6 antibody validated for immunohistochemistry?

Yes, Triple Point Biologics antibodies are validated for immunohistochemistry as part of our standard platform. For ADAMTS-6 IHC, expect predominantly extracellular matrix staining given the secreted, ECM-localized nature of this protease. Antigen retrieval is typically required; citrate buffer (pH 6.0) heat-induced epitope retrieval is a reasonable starting point. Because ADAMTS-6 expression can be focal and context-dependent, include appropriate positive control tissues. Lung adenocarcinoma samples have shown ADAMTS-6 expression in recent studies examining epithelial-mesenchymal transition, making them potentially useful positive controls.

Does this antibody cross-react with other ADAMTS family members?

The ADAMTS family comprises 19 members with conserved domain architecture, so cross-reactivity is a valid concern. This rabbit polyclonal was raised against ADAMTS-6-specific epitopes, but we recommend confirming specificity for your application. Run lysates from cells with known differential expression of ADAMTS family members, or use siRNA/CRISPR knockdown of ADAMTS6 as a negative control. If you observe unexpected bands or staining patterns, consider that some may represent ADAMTS-6 processing fragments rather than cross-reactivity. We have not systematically tested this antibody against all 18 other ADAMTS proteins.

Will this antibody work with dog samples?

Dog (canine) reactivity is predicted based on sequence homology between human and dog ADAMTS-6 orthologs, but has not been experimentally validated in our hands. The conserved regions show high identity, suggesting the antibody should recognize canine ADAMTS-6, but we recommend treating dog samples as experimental until you confirm detection. Run a known positive control (validated human sample) in parallel with your canine samples. If working with dog tissues, lung or cartilage may provide reasonable starting material given ADAMTS expression patterns, though specific canine ADAMTS-6 expression atlases remain limited.

Should I use cell lysate or conditioned medium to detect ADAMTS-6?

Because ADAMTS-6 is a secreted metalloprotease that localizes to the extracellular matrix, conditioned medium often yields stronger signal than whole cell lysates, particularly for cells actively secreting the protein. Concentrate conditioned medium 10-20 fold using centrifugal filters (30-50 kDa MWCO) before loading. For adherent cells, consider collecting the ECM fraction using established protocols, as mature ADAMTS-6 associates with matrix components. If using lysates, include both intracellular and membrane fractions. The choice depends on whether you are studying biosynthesis (lysate) versus secretion and ECM deposition (conditioned medium, ECM fraction).

What controls should I include when working with ADAMTS-6 antibody?

For Western blot, include a positive control cell line or tissue known to express ADAMTS-6. Lung adenocarcinoma cell lines undergoing EMT have documented ADAMTS-6 expression. A negative control using ADAMTS6 knockout or stable knockdown cells is ideal for confirming band identity. For IHC, run serial sections with and without primary antibody, and consider peptide competition if you have access to the immunogen sequence. Because ADAMTS-6 substrate specificity remains incompletely characterized, functional validation (protease activity assays, substrate degradation) can complement immunodetection when studying biological roles.

How should I store this antibody and what is the shelf life?

Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can compromise polyclonal antibody performance. The 100 µg pack size allows you to prepare multiple working aliquots. In our experience, properly stored aliquots maintain activity for at least two years from the manufacturing date. For short-term use (up to one month), diluted antibody can be stored at 4°C with 0.02 percent sodium azide as preservative. Avoid storing diluted antibody long-term, as this increases degradation risk. If you observe reduced signal over time, prepare a fresh aliquot rather than increasing concentration.

Western blot validation for RP-ADAMTS6 — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

ADAMTS-6: Thrombospondin domain #2 — WB validation
WB · Panel 1 ADAMTS-6: Thrombospondin domain #2
ADAMTS-6: First furin cleavage site of the propeptide domain — WB validation
WB · Panel 2 ADAMTS-6: First furin cleavage site of the propeptide domain
ADAMTS-6: Propeptide domain — WB validation
WB · Panel 3 ADAMTS-6: Propeptide domain

Custom validation studies available on request — contact us.

Also known as:

  • A disintegrin and metalloproteinase with thrombospondin motifs 6
  • ADAM-TS 6
  • ADAM-TS6
  • ADAMTS-6
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →